Healthcare

Premium

Healthcare

22 July, 2024

Searchlight: Pulse Pharma's revenue is slowing again. Can it pick up pace?

Hyderabad-based therapeutic medicines manufacturer, Pulse Pharmaceuticals Pvt. Ltd is estimated to clock a lean revenue growth for the financial year ......

Healthcare

19 July, 2024

Accel, IvyCap make startup bets; Lifetime Health gets funding

Artificial intelligence-powered personalization platform Fibr, healthcare services startup Lifetime Health and sales development platform, Pintel.ai raised early-stage funding, the companies said ......

Premium

Healthcare

18 July, 2024

Quadria Capital mulls another exit from India portfolio

Healthcare-focused private equity firm Quadria Capital is planning to offload its stake in an India portfolio company that it backed ......

Premium

Healthcare

18 July, 2024

Bottomline: Can PE-backed Accumax turn around after Covid slump?

Healthcare equipment manufacturer Accumax Lab Devices Pvt. Ltd, backed by private equity firms like Creador and healthcare-focused InvAscent, is aiming ......

Pro

Healthcare

17 July, 2024

Can TPG beat exit benchmark as IPO-bound portfolio firm targets rich valuation?

Private equity firm TPG has set the ball rolling to monetize its investment in another Indian company, as it extends ......

Premium

Healthcare

15 July, 2024

TA Associates-backed OmniActive Health prepares war chest for acquisitions

OmniActive Health Technologies Ltd, an integrated nutraceutical ingredient maker backed by the US private equity firm TA Associates, has readied a ......

Premium

Healthcare

11 July, 2024

Oncology chain HCG attracts another marquee name for CVC Capital's stake

Another private equity giant has joined the list of global investors vying to acquire CVC Capital Partners' controlling stake in Healthcare ......

Premium

Healthcare

11 July, 2024

Suven Pharma mulls inorganic push for its core business

Private equity giant Advent International-owned Suven Pharmaceuticals Ltd is scouting for acquisitions in the technology space to bolster its contract ......

Healthcare

10 July, 2024

Bain-backed Emcure Pharma jumps 35% on listing at $223 mn valuation

Indian drugmaker Emcure Pharmaceuticals' shares rose 34.9% in debut trade on Wednesday, beating analysts' estimates and valuing the company at ......

Premium

Healthcare

10 July, 2024

Iron Pillar, Kalaari & Navam-backed Vyome set for NASDAQ debut with reverse merger

Vyome Therapeutics Inc, a clinical-stage healthcare company targeting immunoinflammatory and rare diseases in the US and other global markets, has ......